🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation — need advice Page 3

SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation — need advice

PharmacoVig_BOS Fri, Mar 28, 2025 at 7:05 PM 15 replies 1,430 viewsPage 3 of 3
DanielChem_CHI
Senior Member
1,234
5,678
Mar 2024
Chicago, IL
Mar 28, 2025 at 11:20 PM#11

+1 to LarryQC_SD. Especially the point about "Re: SURPASS 1-5 program — the subgroup a..." — I have seen the same in my own experience with SURPASS 1-5 program.

38 7fiona_VT, denise_HTX, raj_cambridge and 35 others
Reply Quote Save Share Report
wendy_avl
Member
245
1,123
Oct 2024
Asheville, NC
Mar 28, 2025 at 11:37 PM#12

Want to share my personal experience related to SURPASS 1-5 program since I think it might help others in a similar situation.

I started my GLP-1 journey in March 2025 at 246 lbs with metabolic syndrome. My telehealth provider prescribed semaglutide 0.25mg to start.

Now, 14 months later: I am down 36 lbs, my labs have normalized, and my sleep apnea has improved dramatically. The SURPASS 1-5 program aspect specifically was something that made a big difference in my journey.

This forum was my go-to resource throughout.

Last edited: Mar 29, 2025 at 5:37 AM
38 6DoseLogDan, SleepFixSam, PurityPaulOR and 35 others
Reply Quote Save Share Report
bri_stats
Member
789
3,456
May 2024
Seattle, WA
Mar 28, 2025 at 11:54 PM#13

MASHdoc_SA — that is really helpful context on SURPASS 1-5 program. Follow-up question: did you change anything about your diet at the same time?

I am in a similar situation (month 2) and trying to set realistic expectations.

16 19TomFromTexas, mike.trainer_LA, sarah_nash92 and 13 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.MetabolicMD
VIP Member
2,345
16,789
Jan 2024
Rochester, MN
Mar 29, 2025 at 12:11 AM#14

To answer wendy_avl's question specifically:

From a clinical standpoint, SURPASS 1-5 program is well-supported by the literature.

The short answer: follow the standard titration protocol and reassess at 4-6 weeks.

The longer answer involves pharmacokinetic considerations around steady-state concentrations, which I am happy to elaborate on if helpful.

46 19Dr.ObesityMed, HealthEcon_DC, PedsEndoPhilly and 43 others
Reply Quote Save Share Report
zoe_NC
Member
278
1,234
Nov 2024
Charlotte, NC
Mar 29, 2025 at 12:28 AM#15

Saving this for reference. Top-tier content.

21 23mike_mealprep, NicoleRaleigh, james_edin and 18 others
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register